Efficacy and safety of tocilizumab in Korean patients with active rheumatoid arthritis.
| Author | |
|---|---|
| Abstract |
:
To investigate the efficacy and safety of tocilizumab (TCZ) humanized anti-interleukin-6 receptor monoclonal antibody, in Korean patients with active rheumatoid arthritis (RA) refractory to conventional disease modifying anti-rheumatic drugs (DMARDs) including methotrexate (MTX). |
| Year of Publication |
:
2018
|
| Journal |
:
The Korean journal of internal medicine
|
| Date Published |
:
2018
|
| ISSN Number |
:
1226-3303
|
| DOI |
:
10.3904/kjim.2017.159
|
| Short Title |
:
Korean J Intern Med
|
| Download citation |
